Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers

The clinical outcome of contralateral prophylactic mastectomy (CPM) in women with a BRCA1 or BRCA2 mutation and a personal history of invasive breast cancer is unknown. We identified a cohort of 148 female BRCA1 or BRCA2 mutation carriers (115 and 33, respectively) who previously were treated for un...

Descripción completa

Detalles Bibliográficos
Autores principales: van Sprundel, T C, Schmidt, M K, Rookus, M A, Brohet, R, van Asperen, C J, Rutgers, E J Th, van‘t Veer, L J, Tollenaar, R A E M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361560/
https://www.ncbi.nlm.nih.gov/pubmed/16052221
http://dx.doi.org/10.1038/sj.bjc.6602703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361560/
https://www.ncbi.nlm.nih.gov/pubmed/16052221
http://dx.doi.org/10.1038/sj.bjc.6602703

Ejemplares similares